Portal de investigación
Patients with bladder cancer have an increased NETosis and impaired DNaseI-mediated NET degradation, which can be therapeutically restored in vitro
Autores de IIS La Fe
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Proyectos y Estudios Clínicos
NUEVOS MÉTODOS DIAGNÓSTICOS Y PRONÓSTICOS DEL CÁNCER Y SUS COMPLICACIONES TROMBÓTICAS (DIPROCAT).
Investigador Principal: PILAR MEDINA BADENES
PI17/00495 . INSTITUTO DE SALUD CARLOS III . 2018
HIGHCAT-Identification of patients at HIGH risk of developing urological cancer and Cancer-Associated Thrombosis based on innovative clinical markers and liquid biopsy.
Investigador Principal: PILAR MEDINA BADENES
PI20/00075 . INSTITUTO DE SALUD CARLOS III . 2021
Contrato PFIS 2021. Raquel Herranz
Investigador Principal: PILAR MEDINA BADENES
FI21/00171 . INSTITUTO DE SALUD CARLOS III . 2022
Cita
Herranz,R,Oto,J,Hueso,M,Plana,E,Cana,F,Aleman,,Bonanad,S et al. Patients with bladder cancer have an increased NETosis and impaired DNaseI-mediated NET degradation, which can be therapeutically restored in vitro. RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS:ELSEVIER. 2023.